Advertisement
Pembrolizumab (Keytruda) may extend survival for patients with advanced non-small-cell lung cancer

Pembrolizumab Shows Promise in Metastatic NSCLC

0
In study, the immune-based therapy beat docetaxel with fewer side effects
Many patients with diagnosed obstructive sleep apnea are not being treated

Many Patients With Diagnosed OSA Not Receiving Treatment

0
Forty-two percent report adherence to PAP; 35 percent of untreated patients referred for management
For individual patients with poorly-controlled asthma

Nasal, Pharyngeal EPX Levels Linked to Sputum Eosinophilia

0
Strong correlation seen for eosinophil peroxidase levels in adults with poorly-controlled asthma
There's been a sharp rise in the number of industry-funded clinical trials and a significant decline in those financed by the U.S. government in recent years

Industry Outpacing NIH in Funding Research

0
Analysis finds studies paid for by private sector increasing, while U.S.-sponsored trials decline
The majority of U.S. hospitals don't require health care providers to get a seasonal flu vaccine

Roughly Half of U.S. Hospitals Require Staff Flu Vaccination

0
And only 1.3 percent of VA hospitals mandate vaccination for health care workers
About 20 percent of patients administered fresh frozen plasma (FFP) to reverse warfarin anticoagulation develop pulmonary complications

Dose-Linked Pulmonary Complications After FFP Infusion

0
In warfarin reversal, highest risk with more than three units of fresh frozen plasma
Omalizumab appears to be highly effective for the management of severe allergic asthma

Omalizumab Highly Effective for Severe Allergic Asthma

0
Review of "real-life" studies shows improvements across objective and subjective burden of illness
Implementation of a new model of care can improve outcomes of care in medical and surgical units

New Model of Inpatient Care Can Improve Outcomes

0
Model aims to up interprofessional collaboration, data-driven decisions, provide leadership
More frequent monitoring may be required when patients are taking both acenocoumarol and levofloxacin due to the possibility of an adverse interaction

Interaction Described Between Acenocoumarol, Levofloxacin

0
Probable interaction described in five patients, all of whom had atrial fibrillation
For patients with chronic kidney disease and congestive heart failure undergoing coronary procedures

Central Venous Pressure-Guided Hydration Beneficial in CKD, CHF

0
Reduced risk of contrast-induced nephropathy with no increase in acute heart failure